<DOC>
	<DOCNO>NCT00697112</DOCNO>
	<brief_summary>The purpose observational study examine clinical outcome use sirolimus base therapy kidney allograft recipient Expanded Criteria Donors ( ECD ) condition routine clinical practice . The primary objective identify current criteria/reasons use sirolimus base therapy select population define understand emerge pattern immunosuppressive treatment sirolimus .</brief_summary>
	<brief_title>Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors ( ECD )</brief_title>
	<detailed_description>pilot study</detailed_description>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients age 18 year old . Patients receive renal transplant ( primary , secondary , tertiary , etc . ) without pancreas , Expanded Criteria Donors ( ECD ) , 3 month prior later 1 year time study enrollment . Patients provide informed consent . Patients without sirolimus base therapy . Patients unwilling unable provide inform consent lack legal guardian designee able provide consent behalf . Patients unable complete study . Patients participate another clinical trial last 6 month . Pregnant lactating patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>